欧洲药品安全沟通:现行实践与全科医生认知及偏好
本研究通过调查欧洲国家药品监管机构(NCA)和9国全科医生(GP),评估药品安全沟通实践及GP的认知与偏好。结果显示NCA沟通方式相似,超90%的GP知晓紧急沟通信,偏好发送者为NCA和专业机构,渠道偏好药品参考书和临床指南,重复提醒被认为有用,电子版偏好因国家而异。
要点
- 超90%的GP知晓直接医疗专业沟通信(DHPC)。
- GP偏好NCA和专业机构作为安全信息发送者。
- GP偏好通过药品参考书和临床指南获取安全信息。
核心结论
- NCA使用相似的药品安全沟通方法,大多数GP知晓紧急沟通,偏好发送者相似但格式偏好因国家而异。
研究设计与样本
- 基于网络的调查,分发至27个欧洲国家NCA代表及9个欧洲国家的医疗专业人员,分析GP数据。
主要发现
- 26个国家报告了NCA实践:23国(88%)在网站发布DHPC并分发给个人HCP;10国(40%)网站提供教育材料;21个NCA(81%)有公告/通讯,15国(60%)常展示于网站。
- 1766名完成调查的GP中超过90%知晓DHPC。
- GP认为重复安全信息有用,范围从英国80%到意大利97%。
- 偏好电子版而非纸质版的比例因国家而异,从瑞典36%到西班牙72%。
临床怎么用
- 临床药师可参考GP偏好,通过NCA和专业机构发送安全信息,并利用药品参考书和临床指南传递信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: National competent authorities (NCAs) for medicines coordinate communication relating to the safety of medicines in Europe. The effectiveness of current communication practices has been questioned, particularly with regard to reaching general practitioners (GPs). OBJECTIVE: The aim of this study was to assess current European NCA safety communication practices and to investigate European GPs' awareness of and preferences for safety communications on medicines. METHODS: Web-based surveys were distributed among European NCAs and healthcare professionals (HCPs). The survey among regulators was emailed to a representative of each of the 27 European countries participating in the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action. HCPs from nine European countries (Denmark, Spain, Croatia, Ireland, Italy, The Netherlands, Norway, Sweden, and the UK) were asked about their preferences through a link to the survey on websites, in newsletters, and/or in a direct email. From this survey, data from GPs were used and descriptive analyses were conducted. RESULTS: Current NCA practices were reported for 26 countries. In 23 countries (88%), NCAs published direct healthcare professional communications (DHPCs, i.e. urgent communication letters for serious safety issues) on their website in addition to distribution to individual HCPs. Educational materials were available on the NCA's website in 10 countries (40%), and 21 NCAs (81%) indicated they had their own bulletin/newsletter, which is often presented on the NCA's website (15 countries; 60%). More than 90% of the 1766 GPs who completed the survey were aware of DHPCs. The most preferred senders of safety information were NCAs and professional bodies, while the preferred channels for keeping up to date with safety information were medicines reference books and clinical guidelines. GPs found the repetition of safety issues useful (range of 80% in the UK to 97% in Italy). Preference for an electronic copy rather than a hardcopy varied per country (36% in Sweden to 72% in Spain). CONCLUSIONS: NCAs use similar methods for safety communications on medicines. Most GPs were aware of urgent communications and preferred similar senders of safety communications; however, their preferences towards the format differed per country.
引用
- de Vries ST, van der Sar MJM, Cupelli A, et al. Communication on Safety of Medicines in Europe: Current Practices and General Practitioners' Awareness and Preferences. Drug Saf. 2017. PMID: 28540672. doi:10.1007/s40264-017-0535-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。